Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
abbvie
biotech
fda
national top stories
new york blog main
acorda therapeutics
allergan
amgen
ampyra
apokyn
apomorphine
bempedoic acid
biohaven
boston blog main
boston top stories
cgpr
cholesterol
corticosteroids
dalfampridine
detroit
detroit blog main
detroit top stories
duopa
eli lilly
esperion therapeutics
europe blog main
ezetimibe
fluoroquinolones
inbrija
merck
migraine
mylan
national
new york
new york top stories
parkinson's disease
paul matteis
What
approved
3
×
fda
nod
3
×
drug
medicines
new
pill
treatment
wins
acorda
adults
allergan
cholesterol
class
combo
cope
disease
episodes
esperion
esperion’s
friday
gets
help
late
levels
looms
lowering
meant
medications
migraine
monday
pairs
parkinson’s
patients
regulatory
rival
second
single
stop
therapeutics
Language
unset
Current search:
nod
×
approved
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms